Bacterial Surinfections in COVID-19 ICU Patients : Incidence and Predictive Value of Bacterial Surinfections on In-hospital Mortality in COVID-19 ICU Patients: a Longitudinal Single-center Study

The aim of this study is to assess the incidence of bacterial surinfections (sepsis, VAP and catheter infections) in COVID-19 patients admitted to the ICU from 13th of March 2020 until 17h of October 2020. In addition, the association of these infections with the dose of corticosteroids, the length of stay in ICU and in hospital, the presence of venous thromboembolism, the number of bacterial episodes, the different types of bacteria causing the infections and ICU mortality will be evaluated as well as the associations between the presences of thrombi and bacteremia/catheter sepsis..

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

ClinicalTrials.gov - (2021) vom: 07. Mai To Main Record - year:2021

Language:

English

Links:

Volltext [Kostenfrei]

Keywords:

610
Medical Condition: Covid19
Recruitment Status: Not yet recruiting
Study Type: Observational

Notes:

Source: Link to the current ClinicalTrials.gov record., First posted: May 7, 2021, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021

NCTID:

04877808

Study Publications:

PPN (Catalogue-ID):

CTG00746889X